CVS Health (CVS) Tops Q4 EPS by 4c; Confirms Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to CVS Health (CVS) Tops Q4 EPS by 4c; Confirms Outlook

CVS Health (CVS) PT Raised to $89 at UBS

February 10, 2017 8:51 AM EST

UBS analyst Michael Cherny reiterates Buy rating and raises price target on CVS Health Corp. (NYSE: CVS) to $89 (from $88.50), suggesting the companys continued PBM net new business is offset by ongoing weakness in retail.

Cherny comments, "CVS 4Q had a number of... More

CVS Health (CVS) PT Lowered to $84 at Evercore ISI; Keeps 'Buy'

February 9, 2017 12:11 PM EST

Evercore ISI lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.50) while maintaining a Buy rating. The analyst said management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates.

Analyst Ross Muken commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below dollar profit... More